Pazopanib in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer - Related Studies

Pazopanib in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer

This study is currently recruiting participants.

Study NCT00454142. Last updated on October 22, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Head and Neck Cancer

2	Additional conditions recognized in this trial
		Head and Neck Neoplasms
		Nasopharyngeal Neoplasms

3	More general conditions related to this trial
		Nasopharyngeal Diseases
		Neoplasms
		Neoplasms by Site
		Otorhinolaryngologic Diseases
		Otorhinolaryngologic Neoplasms
		Pharyngeal Diseases
		Pharyngeal Neoplasms
		Stomatognathic Diseases

4	Interventions listed in this trial
		pazopanib hydrochloride
		computed tomography
		pharmacological study

5	Sponsors listed in this trial
		Cancer Therapeutics Research Group
		National Cancer Institute (NCI)